These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15264876)

  • 1. In vitro and in vivo comparison of human Escherichia coli heat-stable peptide analogues incorporating the 111In-DOTA group and distinct linker moieties.
    Giblin MF; Gali H; Sieckman GL; Owen NK; Hoffman TJ; Forte LR; Volkert WA
    Bioconjug Chem; 2004; 15(4):872-80. PubMed ID: 15264876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo evaluation of 111In-labeled E. coli heat-stable enterotoxin analogs for specific targeting of human breast cancers.
    Giblin MF; Gali H; Sieckman GL; Owen NK; Hoffman TJ; Volkert WA; Forte LR
    Breast Cancer Res Treat; 2006 Jul; 98(1):7-15. PubMed ID: 16724166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilized (111)in-labeled sCCK8 analogues for targeting CCK2-receptor positive tumors: synthesis and evaluation.
    Roosenburg S; Laverman P; Joosten L; Eek A; Oyen WJ; de Jong M; Rutjes FP; van Delft FL; Boerman OC
    Bioconjug Chem; 2010 Apr; 21(4):663-70. PubMed ID: 20302291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective targeting of E. coli heat-stable enterotoxin analogs to human colon cancer cells.
    Giblin MF; Sieckman GL; Watkinson LD; Daibes-Figueroa S; Hoffman TJ; Forte LR; Volkert WA
    Anticancer Res; 2006; 26(5A):3243-51. PubMed ID: 17094436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
    Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
    Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical synthesis of Escherichia coli ST(h) analogues by regioselective disulfide bond formation: biological evaluation of an (111)In-DOTA-Phe(19)-ST(h) analogue for specific targeting of human colon cancers.
    Gali H; Sieckman GL; Hoffman TJ; Owen NK; Mazuru DG; Forte LR; Volkert WA
    Bioconjug Chem; 2002; 13(2):224-31. PubMed ID: 11906259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of three 64Cu-labeled E. coli heat-stable enterotoxin analogues for PET imaging of colorectal cancer.
    Liu D; Overbey D; Watkinson LD; Smith CJ; Daibes-Figueroa S; Hoffman TJ; Forte LR; Volkert WA; Giblin MF
    Bioconjug Chem; 2010 Jul; 21(7):1171-6. PubMed ID: 20536242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.
    Achilefu S; Srinivasan A; Schmidt MA; Jimenez HN; Bugaj JE; Erion JL
    J Med Chem; 2003 Jul; 46(15):3403-11. PubMed ID: 12852770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.
    Su FM; Beaumier P; Axworthy D; Atcher R; Fritzberg A
    Nucl Med Biol; 2005 Oct; 32(7):741-7. PubMed ID: 16243650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of 64Cu- and 125I-radiolabeled bitistatin as potential agents for targeting alpha v beta 3 integrins in tumor angiogenesis.
    McQuade P; Knight LC; Welch MJ
    Bioconjug Chem; 2004; 15(5):988-96. PubMed ID: 15366951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of pharmacokinetics of radioiodinated sugar-conjugated somatostatin analogues by variation of peptide net charge and carbohydration chemistry.
    Schottelius M; Rau F; Reubi JC; Schwaiger M; Wester HJ
    Bioconjug Chem; 2005; 16(2):429-37. PubMed ID: 15769098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of 177Lu- and 90Y-labeled E. coli heat-stable enterotoxin for specific targeting of uroguanylin receptors on human colon cancers.
    Giblin MF; Sieckman GL; Shelton TD; Hoffman TJ; Forte LR; Volkert WA
    Nucl Med Biol; 2006 May; 33(4):481-8. PubMed ID: 16720239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of 111In- and 99mTc-labeled quinolin-4-one peptidomimetics as ligands for the vitronectin receptor: potential tumor imaging agents.
    Harris TD; Kalogeropoulos S; Nguyen T; Dwyer G; Edwards DS; Liu S; Bartis J; Ellars C; Onthank D; Yalamanchili P; Heminway S; Robinson S; Lazewatsky J; Barrett J
    Bioconjug Chem; 2006; 17(5):1294-313. PubMed ID: 16984141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide.
    Dijkgraaf I; Liu S; Kruijtzer JA; Soede AC; Oyen WJ; Liskamp RM; Corstens FH; Boerman OC
    Nucl Med Biol; 2007 Jan; 34(1):29-35. PubMed ID: 17210459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein.
    Buchsbaum DJ; Khazaeli MB; Axworthy DB; Schultz J; Chaudhuri TR; Zinn KR; Carpenter M; LoBuglio AF
    Clin Cancer Res; 2005 Nov; 11(22):8180-5. PubMed ID: 16299250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the molecular charge on the biodistribution of bombesin analogues labeled with the [99mTc(CO)3]-core.
    García Garayoa E; Schweinsberg C; Maes V; Brans L; Bläuenstein P; Tourwe DA; Schibli R; Schubiger PA
    Bioconjug Chem; 2008 Dec; 19(12):2409-16. PubMed ID: 18998719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [111In-DOTA]LTT-SS28, a first pansomatostatin radioligand for in vivo targeting of somatostatin receptor-positive tumors.
    Maina T; Cescato R; Waser B; Tatsi A; Kaloudi A; Krenning EP; de Jong M; Nock BA; Reubi JC
    J Med Chem; 2014 Aug; 57(15):6564-71. PubMed ID: 25007399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo evaluation of 64Cu-labeled DOTA-linker-bombesin(7-14) analogues containing different amino acid linker moieties.
    Parry JJ; Kelly TS; Andrews R; Rogers BE
    Bioconjug Chem; 2007; 18(4):1110-7. PubMed ID: 17503761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabeled alpha-melanocyte-stimulating hormone analogs for receptor-mediated targeting of melanoma: from tritium to indium.
    Eberle AN; Froidevaux S
    J Mol Recognit; 2003; 16(5):248-54. PubMed ID: 14523936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin receptor-binding peptides suitable for tumor radiotherapy with Re-188 or Re-186. Chemistry and initial biological studies.
    Cyr JE; Pearson DA; Wilson DM; Nelson CA; Guaraldi M; Azure MT; Lister-James J; Dinkelborg LM; Dean RT
    J Med Chem; 2007 Mar; 50(6):1354-64. PubMed ID: 17315859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.